about
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyReactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heartQuantification of protein expression changes in the aging left ventricle of Rattus norvegicusMyc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice.Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic miceMitochondrial energy metabolism plays a critical role in the cardioprotection afforded by intermittent hypobaric hypoxia.Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heartSubcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytesEndurance training or beta-blockade can partially block the energy metabolism remodeling taking place in experimental chronic left ventricle volume overloadThe story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humansMalondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetesEnergy metabolism in heart failure and remodelling.Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance.Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemiaMesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart.PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways.The role of cardiac PET in translating basic science into the clinical arena.MRS: a noninvasive window into cardiac metabolism.A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy.Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosisExendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice.Telomere length and outcome in heart failure.Comparative phenotypic assessment of cardiac pathology, physiology, and gene expression in C3H/HeJ, C57BL/6J, and B6C3F1/J mice.Down-regulated energy metabolism genes associated with mitochondria oxidative phosphorylation and fatty acid metabolism in viral cardiomyopathy mouse heart.Metabolic Mechanisms of Exercise-Induced Cardiac Remodeling
P2860
Q26765793-EDEC96CB-58B7-4942-8CFC-4265A365298DQ26849625-2A621EBF-507A-4503-A236-7444DACF6AE7Q33482348-A85DC348-9DC8-42C8-9101-8D4B10A60274Q33815625-937B9F60-12DF-40B8-A604-66ACC1AFC700Q34162518-99BDD626-3D4B-41A6-8B0E-4A290EFC32BEQ34259423-F63071CD-AE6D-406C-8901-3DD6AE2A570CQ34796354-39E81649-532E-4690-8F75-D7E264AA2241Q35100504-C60A1540-2DE8-4FB3-BD0D-30FB21463FB6Q35527626-6893A386-F3F1-4393-9A74-D889D3E7BDA6Q35964903-B7B01316-E995-4682-A633-850D3BCDDC8EQ36339625-BB09220D-BEFB-4038-902A-ED5B693A0377Q36485424-F736F29C-A5FC-4A3C-9525-EE665C31F210Q37090565-9AEF7463-2767-4114-90DC-8C14DCF29DE6Q37263689-AE2C4906-0212-4DAB-A6F2-AACDEBB7265EQ37264406-1DEB0332-8F96-462A-9581-916937744CB1Q37310637-E20ABB02-2579-4747-A002-2422B788A79FQ37357426-C47639D8-C46F-40A3-9BC5-ACD1AA1DD562Q37779741-9B6F8A34-B817-45A8-AB7C-7C0AB392545FQ37875793-A12EE7F8-94FE-40F6-AA59-40C1797A8AC2Q38502630-782CF40A-A7C7-4095-970E-06B1FF69B5F2Q38830822-78741144-CA8E-4DF8-A527-2598995ADF6DQ42124714-4021FBF6-0FD9-40ED-A5C1-8C5B925E7792Q44660682-E0E03ABE-9F86-452A-B07F-DC416B93D871Q48251771-D451EA42-8CD2-4692-8A23-F8C3B7E1E576Q48397648-6E79E6F0-20EA-4FF6-8AB9-547CD9D01C85Q53452720-919E326D-B5DD-4C78-B6F3-F36908968FA4Q54398985-2CB2C931-6783-4FCA-B22A-6D91D3B02995Q58750834-AC6FCB71-CE6A-44E0-9014-39CB8B73C50E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alterations in energy metabolism in cardiomyopathies.
@en
type
label
Alterations in energy metabolism in cardiomyopathies.
@en
prefLabel
Alterations in energy metabolism in cardiomyopathies.
@en
P2860
P1433
P1476
Alterations in energy metabolism in cardiomyopathies.
@en
P2093
Gary D Lopaschuk
Maysa Taha
P2860
P304
P356
10.1080/07853890701618305
P407
P577
2007-01-01T00:00:00Z